Megan Othus, PhD

Professor
University of Washington, United States

Presentation(s):

• 53: Surgical Outcomes of SWOG1801: Neoadjuvant/adjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma

  Friday, March 24, 2023
  1:25 PM – 1:37 PM

  Disclosure information not submitted.